Live
- Nepal's disasters cause huge loss in late September
- Congress not finished but BJP survives on backs of Nitish, Chandrababu: Nana Patole
- Calcutta High Court advises Bengal government to fix guidelines for demonstration sites
- 25 per cent of Indians affected by Varicose Veins, say health experts
- Congress launches 'Delhi Nyay Yatra' to expose AAP govt's failure
- LIC clocks net profit of Rs 7,621 crore in July-September quarter
- Rising Rajasthan Pre-Summit: MoUs worth Rs 63,463 crore signed in mining, petroleum sector
- Swiggy's IPO subscribed 3.59 times on last day
- Hold gram panchayats in villages to make decision public, Kejriwal tells sarpanches in Punjab
- Calcutta High Court stays suspension of 7 medical students on ragging charges
Dr Reddy's launches Avigan tablets in India for Coronavirus
Representational Pic
Pharma major Dr Reddy's Laboratories Ltd on Wednesday announced the launch of Avigan (Favipiravir) 200 mg tablets for treatment of Covid-19 in India
Hyderabad: Pharma major Dr Reddy's Laboratories Ltd on Wednesday announced the launch of Avigan (Favipiravir) 200 mg tablets for treatment of Covid-19 in India.
The launch is part of the global licensing agreement with Fujifilm Toyama Chemical Co. Ltd that grants Dr Reddy's the exclusive rights to manufacture, sell and distribute Avigan (Favipiravir) 200 mg tablets in India.
Avigan has been approved by the Drugs Controller General of India (DCGI) for the treatment of patients with mild to moderate Covid-19 disease.
"We are pleased to bring this important innovator medicine to the patients in India.AThe need for high quality and efficacy, affordability and better disease management are key priorities for us. We believe that Avigan would provide an effective treatment option to the Covid-19 impacted patients in India," said M.V. Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), Dr Reddy's Laboratories.
Dr Reddy's Avigan comes in a complete therapy pack of 122 tablets with a two-year shelf life.
To ensure accelerated access to the medicine, Dr Reddy's has initiated a free home delivery service in 42 cities in the country, and a helpline centre at 1800-267-0810/www.readytofightcovid.in between 9 a.m. to 9 p.m. Monday to Saturday.
